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Background: Prominent visual symptoms can present in the visual variant of Alzheimer’s disease (VVAD).
Ophthalmologists have a significant role to play in the early diagnosis of VVAD.
Methods: We retrospectively reviewed the files of ten consecutive patients diagnosed with VVAD. All patients
had a full neuro-ophthalmologic examination, a formal neurological and neuro-psychological testing, and
cerebral MRI to confirm diagnosis. In addition, functional neuroimaging was obtained in seven patients.
Results: The common primary symptom at presentation with all patients was difficulty with near vision
(reading difficulty n = 8, “visual blur” in near vision n = 2), and difficulty writing (n = 3). Following assessment,
impaired reading and writing skills were evident in 9/10 and 8/10 patients respectively. Median distance visual
acuity was 20/25 and at near the median visual acuity was J6. Partial homonymous visual field defect was
detected in 80 % (8/10) of the patients. Color vision was impaired in all patients when tested with Ishihara
pseudoisochromatic plates, but simple color naming was normal in 8/9 tested patients. Simultanagnosia was
present in 8/10 patients. Vision dysfunction corresponded with cerebral MRI findings where parieto-occipital
cortical atrophy was observed in all patients. PET scan (5 patients) or SPECT (2 patients) revealed parieto-occipital
dysfunction (hypometabolism or hypoperfusion) in all 7 tested patients
Conclusions: Visual difficulties are prominent in VVAD. Dyslexia, incomplete homonymous hemianopia, preserved color
identification with abnormal color vision on Ishihara, and simultanagnosia were all symptoms observed frequently in
this patient series. Ophthalmologists should be aware of the possibility of neurodegenerative disorders such as VVAD
in patients with unexplained visual complaints, in particular reading difficulties.
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The number of patients presenting in clinic with reading
difficulties increases with age. Most frequently, this com-
plaint is due to either refraction abnormalities, corneal
lesions, cataract, or a retinopathy. However, occasionally
ocular examination shows no pathology with normal
distance visual acuity; in such cases the origin of the
reading difficulties is not evident. In 1988, Benson et al.
reported a series of 5 patients with prominent visual
complaints (reading difficulties) which had no evident
ophthalmological origin. In this series all patients exhibited
Balint’s syndrome (optic ataxia, simultanagnosia, oculo-
motor apraxia) and Gerstmann’s syndrome (acalculia,* Correspondence: francois.borruat@fa2.ch
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creativecommons.org/publicdomain/zero/1.0/agraphia, finger agnosia, right-left confusion). Subsequently,
posterior cortical atrophy was observed on MRI in 4/5
patients [1]. Posterior cortical atrophy (PCA) is a group of
neurodegenerative disorders which affect primarily the
parieto-occipital cortex [2]. Etiologies of PCA include Alz-
heimer’s disease (AD), corticobasal degeneration, dementia
with Lewy bodies, subcortical gliosis, and prion diseases
(Creutzfeldt-Jakob disease, fatal familial insomnia) [1–4].
The most frequent cause of PCA is AD, accounting for
more than 80 % of cases. When AD presents with promin-
ent visual symptoms, it is referred to as “Visual variant of
Alzheimer’s disease” (VVAD) [5].
VVAD is a progressive neurodegenerative disorder in
which visual symptoms are prominent, due to the pre-
dominance of parieto-occipital localization of pathologic
changes. Neurofibrillary tangles and senile plaques similarticle distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
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younger than those affected typically by AD [3, 4]. Because
VVAD presents primarily with visual signs and symptoms,
with a relative sparing of memory and other cognitive
functions initially, VVAD patients present first to the oph-
thalmologist [1–3, 6–8].
Since the reported visual symptoms of VVAD are non-
specific, and routine ocular examination is usually non-
conclusive, the ophthalmologist should be aware of the re-
sults of an array of simple clinical tests which are indicative
of VVAD. This report outlines the ophthalmological results
of a series of ten patients with major visual complaints
which lead to the diagnosis of VVAD.
Methods
We reviewed the charts of ten consecutive patients re-
ferred to the neuro-ophthalmology unit of the Jules-
Gonin Eye Hospital between 2002 and 2008 for investi-
gations of unclear visual loss, and ultimately diagnosed
with VVAD.
All patients had a full neuro-ophthalmologic examin-
ation by one of us (FXB) including assessment of dis-
tance and near best corrected visual acuity, color vision
(Ishihara pseudoisochromatic plates), oculomotility, vis-
ual field, slit lamp and fundus examination. Additional
testing included simple mental calculations (additions,
subtractions, divisions and multiplications of 1–2 digit
numbers), writing abilities, reading one’s own handwriting,
and assessment of simultanagnosia using the “Cookie Theft
Picture” (Boston Diagnostic Aphasia Examination). Subse-
quently, all patients benefited from a formal neuropsycho-
logical testing and underwent complete neurological
examination. Cerebral MRI was performed in all patients,
and 7/10 patients underwent also functional cerebral
imaging, either positron emission tomography (PET) or
single photon emission computed tomography (SPECT).
This study was performed in accordance with the te-
nets of the Declaration of Helsinki and was approved by
the Swiss Federal Department of Health (authorization #
035.0003-48). We confirm that consent to publish the
clinical details of patients reported in this study was ap-
proved by the local ethics and research committee.
Report of a case
A 70 year-old woman (patient 9, Table 1) complained of
difficulty reading for one year. Apart from a well-
controlled systemic arterial hypertension, the patient
was in good general health. She did not report any mem-
ory loss or orientation difficulty. Upon examination,
best-corrected visual acuity (VA) was 20/25 at distance
and J4 at near OU. Despite the relatively preserved vis-
ual acuity at near, she experienced major difficulties
while reading. Biomicroscopy and fundus examination
were normal. There was no dysgraphia (Fig. 1), but thepatient could not read her own handwriting 10 min
later. While the results of color vision testing were ab-
normal when tested with Ishihara pseudoisochromatic
plates (0/13 correct answer), simple color identification
and naming were normal and there was no dyschroma-
topsia on a 28-Hue test. There was no dyscalculia. Com-
puterized visual field testing revealed a right partial
homonymous hemianopsia (Fig. 2). Cerebral MRI re-
vealed focal left parieto-occipital atrophy, with no other
structural abnormality (tumor, stroke, demyelination)
(Fig. 3). Results from both neurological and neuropsycho-
logical examinations were conclusive for VVAD. Results
from a PET-scan showed decreased metabolism predom-
inantly of the left parieto-temporo-occipital cortex (Fig. 4).
Acetylcholinesterase inhibitor treatment was introduced
with no favorable effect.
Results
Ten patients were referred for evaluation of unexplained
reading difficulties, ranging from “slow reading” to “im-
possible to read anything”. There were six women and
four men. At the time of examination, the age of the pa-
tients ranged from 58 to 82 years (median 64 years). The
onset of symptoms ranged from 5 months to 4 years be-
fore examination (median 18 months). General health
was good in all patients without any pathology relevant
to the loss of visual performances. The main visual com-
plaint was impaired visual performances at near in all 10
patients. Difficulties in writing were also spontaneously
reported in 3/10 patients. Only 3/10 patients spontan-
eously reported some memory loss, and a neurodegener-
ative disease was initially suspected in only one patient
At distance, the median visual acuity was 20/25 on
Snellen chart (range 20/20–20/80), and at near the me-
dian visual acuity was J6 (range J1-J16). Results from
Ishihara pseudoisochromatic plates testing were abnor-
mal in all 10 patients (median 0/13, range 0/13–6/13),
but simple color naming was normal in 8/9 tested pa-
tients. Formal visual field testing was performed in all
patients under monocular conditions (computerized
static visual field testing in 10 patients, additional Gold-
man kinetic manual perimetry in 4/10 patients). Results
from visual field examination were reliable in only 6 pa-
tients, revealing incomplete homonymous hemianopia in
5/6 patients. Confrontation visual field testing showed
partial homonymous defects in 3 of the 4 remaining pa-
tients. Slit lamp and fundus examination were normal in
all patients.
Reading was impaired in 9/10 patients, and 8/10 had
difficulty writing (Table 1). Simple mental calculation
was impaired in 6/10 patients. Simultanagnosia (inability
to interpret more than one element of a complex visual
scene at the same time) was present in 8/10 patients,
who failed to accurately describe the “Cookie Theft
Table 1 Patients’ characteristics and radiological findings
Patient Sex Age
(yrs)
Chief complaint
(s)
Distance
VA
Near
VA
Visual field Ishihara
plates
Color
naming
Dys-
lexia
Dys-
graphia
Simult-
agnosia
Dys-
calculia
Cerebral MRI (cortical
atrophy)
Functional cerebral
imaging (decreased
metabolism/perfusion)
1 M 58 Difficulty reading
& writing
20/25 J 16 L hemianopsia 0/13 normal + + + + Posterior N.a.
2 F 59 Difficulty reading 20/20 J 4 L hemianopsia 0/13 normal + + + + Parieto-temporal PET: R > L
parietooccipital
3 F 61 Difficulty reading 20/20 J 12 R hemianopsia 0/13 normal + + + + L > R posterior N.a.
4 M 62 Difficulty reading 20/20 J 3 not reliable 0/13 abnormal + + + + bilateral parietooccipital SPECT: parietooccipital
5 M 62 Visual blur 20/50 J 3 R hemianopsia 6/13 normal - + - - Posterior PET: parietooccipital
6 F 65 Visual blur 20/63 J 8 L hemianopsia 3/13 N.a. + + + + Posterior PET: parietooccipital
7 F 68 Difficulty reading 20/25 J 6 R quadranopsia 0/13 normal + - + - L > R partietooccipital PET: parietooccipital
8 M 70 Difficulty reading
& writing
20/63 J 8 R quadranopsia 0/13 normal + + + + Posterior SPECT: parietooccipital
9 F 70 Difficulty reading 20/25 J 4 R hemianopsia 0/13 normal + - - - L partietooccipital PET: L > R
parietooccipital
10 F 82 Difficulty reading
& writing
20/32 J 6 R caeco-central, L
arcuate
0/13 normal + + + - Posterior N.a.
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Fig. 1 Patient 9. A 70 year-old woman complained of difficulty reading, but had a normal distance and near visual acuity. She wrote this
sentence in French: “Today the weather is nice, but I am in the hospital”, but could not read her own handwriting 10 min later
Kaeser et al. BMC Ophthalmology  (2015) 15:65 Page 4 of 7Picture” from the Boston Diagnostic Aphasia Examination.
Optic ataxia (i.e. misreaching of objects under visual guid-
ance) was detected in 9/10 patients. Results from formal
neurological and neuropsychological examinations were ab-
normal in all 10 patients, revealing incomplete presenta-
tions of either Balint syndrome (optic ataxia, oculomotor
apraxia, simultanagnosia) or Gerstmann’s syndrome (alexia,
agraphia, acalculia, digital agnosia, left-right disorientation),
partial prosopagnosia and various degree of memory
deficits and apraxia. Results from the mini mental state
examination (MMSE) were abnormal in 7/10 patients
(median score 16/30, range 30/30–7/30; a score ≤ 24/30
being suspect of cognitive dysfunction). Cerebral MRI
was performed in all patients, and revealed predomin-
antly parieto-occipital cortical atrophy preserving the
primary visual cortical areas in 10/10 patients (bilateral in
7/10 patients, unilateral left atrophy in 3/10 patients). No
other structural abnormality (tumor, stroke, or demyelin-
ation) was detected. Results of PET (5 patients) and
SPECT (2 patients) scans showed parieto-occipital
dysfunction (hypometabolism or hypoperfusion) in all
7 tested patients.
The diagnosis of VVAD was made according to both
clinical and radiological presentations. Specifically, no pa-
tient presented parkinsonism, complained of hallucinations,Fig. 2 Patient 9. Result of computerized visual field examination revealed aor exhibited extrapyramidal signs, myoclonus or ataxia.
The clinical diagnosis of probable VVAD was made
5 months to 4 years after the onset of visual symptoms
(average 18 months).Discussion
In patients aged 50 and above, reading disturbances
are a frequent complaint, generally the origin of which
is clear following a thorough ophthalmological exam.
However, visual disturbances can also be a symptom of
progressive dementia. Differentiating between dementia
and another origin is based on clinical presentation, evo-
lution, neuroradiological results, and sometimes results
of brain biopsy. Alzheimer’s disease (AD) is the most
common neurodegenerative disease, accounting for 50–
65 % of all cases of dementia [9]. Visual impairment has
previously been reported in AD, generally with advanced
disease and severe cognitive impairment. Visual impair-
ment in AD is understood to result from visual cortical
involvement by neurofibrillary tangles and plaques, and
include homonymous hemianopia, visual agnosia, Balint
syndrome [7, 10]. Furthermore, progressive neural tissue
loss in the retina (retinal ganglion cells) may contribute
to the visual symptoms and visual loss in AD [11].right partial homonymous hemianopsia
Fig. 3 Patient 9. Cerebral MRI (T1) showed a left occipito-parietal atrophy (arrows)
Fig. 4 Patient 9. PET-scan disclosed a decrease in parieto-temporo-occipital metabolism (left > right) (arrows)
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form of AD affecting patients of either sex in upper
ranges of middle age. The early onset of visual symp-
toms and their prevalence in VVAD can be explained by
the localization of the associated cortical atrophy, which
in VVAD is predominately observed at the parieto-
occipital lobes, whereas patients with typical AD show
cortical lesions more prominently in the temporo-
parietal lobes [9]. As opposed to the more frequent typ-
ical AD patients, cognitive impairment and/or memory
disturbances are absent or mild, at least during the early
stage of VVAD [1, 4–6]. Because visual symptoms are
prominent manifestations of VVAD, ophthalmologists
are often the first to evaluate these patients [1–3, 6–8].
However, the visual symptoms of VVAD at presentation
are nonspecific, especially with respect to reading
difficulties, “reading glasses do work anymore” or vague
“visual blur”. In all our patients, the degree of visual im-
pairment was marked, and did not correlate with the ex-
pected minor visual impairment or structural ocular
abnormalities that are normally encountered in patients
of this age. Such a discrepancy should raise the suspicion
of VVAD [6, 8].
The signs and symptoms of VVAD depend on whether
the dorsal (occipito-parietal) or ventral (occipito-tem-
poral) visual processing pathway is the primary site of
disease. The dorsal system is the most frequently in-
volved (« where » pathway), resulting in Balint syndrome
(simultanagnosia, oculomotor apraxia, optic ataxia),
Gerstmann syndrome (agraphia, acalculia, right-left dis-
orientation, finger agnosia), dressing apraxia, and apha-
sia. Lesions of the ventral system (« what » pathway)
produce alexia without agraphia, visual object agnosia,
and prosopagnosia (inability to recognize faces) [1–3, 6–8].
A complete Balint or Gerstmann syndrome is rare,
and the most common feature for either syndrome is
simultanagnosia and acalculia [1, 6]. In our series,
80 % of patients exhibited simultanagnosia and dyscal-
culia was observed in 6/10 patients.
As VVAD affects mostly the parieto-occipital cortex,
involvement of the retrochiasmal part of visual pathway
can occur. The occurrence of homonymous visual field
defects in VVAD varies widely in the literature, with a
prevalence ranging from 11 % to 78 % [3, 6, 8, 12–16].
Our results correspond well with the recent report by
Pelak et al., in that homonymous visual field defects
were present in 80 % of the patients reported here [17].
Computerized static visual field techniques are the most
sensitive to detect small paracentral homonymous de-
fects, but unfortunately require a very good cooperation
of the patient, which is diminished in AD patients. Com-
puterized visual field test was performed in all our 10
patients but was judged reliable and interpretable in only
6/10, disclosing homonymous defects in 5/6. In theremaining 4 patients (non reliable), additional testing
with confrontational techniques revealed homonymous
defects in 3/4. Visual neglect can co-exist with hemianopia.
We did not specifically test our patients for hemineglect,
but this can be easily assessed by the ophthalmologist using
a letter cancellation or Bells test.
Abnormal results of color testing (Ishihara pseudo-
isochromatic plates) were present in all our patients
(median 0/13, range 0–6/13). Whereas these results
could suggest moderate to severe dyschromatopsia, nor-
mal results of simple color naming were present in 8/9
tested patients. Such a discrepancy suggests an inability
to derive form from color instead of altered color vision
per se [6]. The abnormal results on Ishihara pseudoiso-
chromatic plates test are then related to simultanagnosia
instead of a true dyschromatopsia. Using a finger to
trace the path on Ishihara color plates could help
separating simultanagnosia from dyschromatopsia in
VVAD patients. Despite obvious cortical atrophy in
VVAD, dyschromatopsia is not typically found in
these patients. Color identification is processed in the
temporo-occipital lobe, area V4, which is not usually
affected in VVAD [17].
When VVAD is suspected, cerebral imaging, formal
neuropsychological and neurological evaluations are
mandatory. Cerebral MRI or CT-scan is necessary to ex-
clude any focal cerebral lesion (stroke, tumor, demyelin-
ation). In VVAD, neuroimaging techniques typically
reveal occipital and/or parietal cortical atrophy, with a
relative sparing of frontal and temporal cortex. This pat-
tern was found in all our patients (Table 1). Functional
cerebral imaging, by PET or SPECT, will usually reveal
parietooccipital dysfunction, even in absence of anatom-
ical cortical atrophy on CT or MRI [3, 6, 8, 12, 18].
Functional imaging was performed in 7/10 patients, and
revealed occipital or occipitoparietal hypoperfusion
(SPECT) or hypometabolism (PET) in all of them
(Table 1). Neuropsychological evaluation was abnormal
in all our patients and disclosed some signs of more
global dementia in all our 10 patients, whereas only 3/10
patients spontaneously reported some memory impair-
ment. Although a formal neuropsychological assessment
is very useful, some higher cortical functions can be
easily assessed by the ophthalmologist: difficulties to
describe a complex scene (simultanagnosia) by showing
a picture from a magazine, the « Cookie Theft Picture »
(Boston Diagnostic Aphasia Examination) or Navon task
stimulus; poor handwriting (dysgraphia); difficulties in
reading despite adequate visual acuity (dyslexia); diffi-
culties with some simple mental mathematical opera-
tions (dyscalculia); difficulties for the patient to reach
under visual guidance an object with his hand (optic
ataxia); and defective generation of saccades (oculomotor
apraxia).
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Ophthalmologists should be aware of the possibility of
VVAD in patients with unexplained visual complaints, in
particular reading difficulties. Some simple clinical
tests can strengthen a suspicion of neurodegenerative
disorder, namely VVAD. The diagnosis needs to be
confirmed by neurological, neuropsychological and
neuroimaging examinations. Early diagnosis may carry
a better prognosis facilitating earlier treatment. An
early diagnosis also allows the organization of special-
ized social care and counselling for the patient and
her/his family.
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